within the swiftly evolving discipline of oncology exploration, exact and productive mutation screening is crucial for producing focused therapies. The KRAS solutions System performs a pivotal function On this landscape by presenting detailed alternatives for KRAS mutation profiling and Evaluation. KRAS mutations, found in roughly ninety five% of R